Triple Artemisinin-based Combination Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Triple Artemisinin-based Combination Therapy, covering 2024-12-11 to 2024-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial [Phase 2, Phase 3]